The PE Ratio as of December 2025 (TTM) for Clover Biopharmaceuticals, Ltd. (2197.HK) is -3.57

According to Clover Biopharmaceuticals, Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -3.57. This represents a change of 586.46% compared to the average of -0.52 of the last 4 quarters.

Clover Biopharmaceuticals, Ltd. (2197.HK) Historical PE Ratio (quarterly & annually)

How has 2197.HK PE Ratio performed in the past?

The mean historical PE Ratio of Clover Biopharmaceuticals, Ltd. over the last ten years is -49.73. The current -3.57 PE Ratio has changed 617.85% with respect to the historical average. Over the past ten years (40 quarters), 2197.HK's PE Ratio was at its highest in in the June 2023 quarter at 0.47. The PE Ratio was at its lowest in in the December 2019 quarter at -113.96.

Clover Biopharmaceuticals, Ltd. (2197.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Clover Biopharmaceuticals, Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clover Biopharmaceuticals, Ltd. (2197.HK) Average PE Ratio

How has 2197.HK PE Ratio performed in the past?

The current PE Ratio of Clover Biopharmaceuticals, Ltd. (2197.HK) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Clover Biopharmaceuticals, Ltd. (2197.HK) PE Ratio vs. Peers

How is 2197.HK’s PE Ratio compared to its peers?

Clover Biopharmaceuticals, Ltd.’s PE Ratio is greater than Jiangsu Recbio Technology Co., Ltd. (-3.64), greater than Antengene Corporation Limited (-10.91), greater than Cutia Therapeutics (-3.74), greater than HighTide Therapeutics Inc (-4.23), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-8.17), less than Frontage Holdings Corporation (72.18), less than JW (Cayman) Therapeutics Co. Ltd (-1.88), less than Jacobson Pharma Corporation Limited (8.31), greater than SinoMab BioScience Limited (-10.41), greater than Mabpharm Limited (-81.81),

Build a custom stock screener for Clover Biopharmaceuticals, Ltd. (2197.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clover Biopharmaceuticals, Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clover Biopharmaceuticals, Ltd. (2197.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clover Biopharmaceuticals, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.